InvestorsHub Logo
Followers 46
Posts 1362
Boards Moderated 0
Alias Born 08/09/2015

Re: None

Saturday, 10/03/2015 9:52:04 PM

Saturday, October 03, 2015 9:52:04 PM

Post# of 461196
Today's WSJ - Jon Palfreman's article: "A new Attack on Parkinson's Disease" mentions that: "Many researchers think that the bad actor in Parkinson's is a simple protein, called alpha-synuclein, gone rouge. The misfolded molecule forms sticky clumps called amyloids that jump from neuron to neuron killing cells. They in particular snuff out the nerve cells that make a crucial brain chemical, the neurotransmitter dopamine."

Mr. Palfreman has Parkinson's disease. He does not mention Anavex in this article. He does mention a product by NeuroPhage in Cambridge, Mass. He says this product is a simple virus- M13. He also mentions that this product holds hope to treat Alzheimer's and Huntington's disease.

Perhaps Mr. Palfreman is not aware of Anavex?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News